Patents
US 11957696 B2: Abiraterone prodrugs
- Granted
- 2024-04-16
- Filed
- 2022-02-14 application 17670712
- Type
- Utility · 21 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Sustained-release abiraterone prodrug formulations, methods, and kits for parenteral administration to a subject having a sex hormone-dependent benign or malignant disorder such as prostate cancer, an androgen receptor driven cancer, a syndrome due to androgen excess, and/or a syndrome due to glucocorticoid excess such as hypercortisolemia.
Source: PVGPATDIS, file of 2026-04-10 (ipg240416.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| PROPELLA THERAPEUTICS, INC. 8 patents | US company or organization | Pittsboro, NC | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Matthew J. SHARP | Apex, NC | 5 | PVGPATDIS, file of 2026-04-10 | |
| William R. Moore | Pittsboro, NC | 12 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K9/0019 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P5/28 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2024-11-15 | Merger Merger | PROPELLA THERAPEUTICS, INC. signed 2024-10-23 | ASTELLAS US LLC NORTHBROOK, IL | 69281/486 | PASDL, file of 2026-10-15 |
| 2022-05-12 | Assignment Assignment of assignor's interest | MOORE, WILLIAM R., JR. signed 2021-02-16 SHARP, MATTHEW J. signed 2021-02-16 | PROPELLA THERAPEUTICS, INC. PITTSBORO, NC | 59968/276 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.